68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate

被引：8

作者：

Qiu, Shuang ^{[1
]}

Dong, Aisheng ^{[1
]}

Zhu, Yan ^{[2
]}

Zuo, Changjing ^{[1
]}

机构：

[1] Navy Med Univ, Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China

[2] Navy Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China

来源：

CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期

关键词：

prostatic ductal adenocarcinoma; PSMA; FDG; PET/CT;

D O I：

10.1097/RLU.0000000000004230

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostatic ductal adenocarcinoma is an uncommon variant of prostatic carcinoma with aggressive behavior and worse prognosis. We describe Ga-68-PSMA-11 and FDG PET/CT findings in a case of prostatic ductal adenocarcinoma with pelvic lymph node metastases. The majority of the prostate tumor and all the metastatic lesions showed no significant PSMA uptake but intense FDG uptake. The role of PSMA and FDG PET in the management of prostatic ductal adenocarcinoma needs to be investigated in a large number of patients.

引用

页码：836 / 838

页数：3

共 50 条

[11] A Comprehensive Safety Evaluation of 68Ga-PSMA-11 PET/CT in Prostate Cancer
Nielsen, Julie B.
Zacho, Helle D.
Haberkorn, Uwe
Nielsen, Karin M.
Dettmann, Katja
Langkilde, Niels C.
Petersen, Lars J.
CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : 520 - 524
[12] 68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma
Zhao, Qian
Yang, Bo
Dong, Aisheng
Zuo, Changjing
CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E101 - E102
[13] Incidental Detection of Prostatic Lesion on 18F-FDG PET/CT and 68Ga-PSMA-11 PET/CT Leading to Diagnosis of Second Primary Prostatic Adenocarcinoma in a Patient of Differentiated Thyroid Cancer
Gondhane, Abhay Indrasingh
Parghane, Rahul V.
Basu, Sandip
CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : e120 - e121
[14] Primary Adenosquamous Carcinoma of the Prostate With Multiple Heterogenic Metastases Demonstrated on 68Ga-PSMA and 18F-FDG PET/CT Imaging
Yang, Jinhui
Xiao, Ling
Gao, Xiaomei
Tang, Yongxiang
Hu, Shuo
CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 180 - 181
[15] A Comparison of 18F-FDG PET/CT and 68Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer
Ozturk, Ahmet Ertugrul
Sahin, Rahime
Ergul, Nurhan
Cermik, Tevfik Fikret
Arslan, Esra
CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : e68 - e69
[16] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
Gundogan, Cihan
Ergul, Nurhan
Cakir, Mehmet Semih
Kilickesmez, Ozgur
Gursu, Riza Umar
Aksoy, Tamer
Cermik, Tevfik Fikret
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
[17] 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Sachpekidis, Christos
Kopka, Klaus
Eder, Matthias
Hadaschik, Boris A.
Freitag, Martin T.
Pan, Leyun
Haberkorn, Uwe
Dimitrakopoulou-Strauss, Antonia
CLINICAL NUCLEAR MEDICINE, 2016, 41 (11) : E473 - E479
[18] PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive
Gauthe, M.
Belissant, O.
Girard, A.
Yin, J. Zhang
Ohnona, J.
Cottereau, A. -S.
Nataf, V.
Balogova, S.
Pontvert, D.
Lebret, T.
Guillonneau, B.
Cussenot, O.
Talbot, J. -N.
PROGRES EN UROLOGIE, 2017, 27 (8-9): : 474 - 481
[19] Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT
Cai, Jiayu
Xu, Weizhi
Meng, Tinghua
Pang, YiZhen
Chen, Haojun
CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : 743 - 745
[20] Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
Zhang, Yan-Nan
Lu, Zhen-Guo
Wang, Shuai-Dong
Lu, Xin
Zhu, Lei-Lei
Yang, Xu
Fu, Li-Ping
Zhao, Jun
Wang, Hai-Feng
Xiang, Zuo-Lin
CANCER IMAGING, 2022, 22 (01)

← 1 2 3 4 5 →